This analysis of the large multinational Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS‐CTO) registry1 examined prevalence, temporal trends, and clinical outcomes of radial versus femoral access in CTO PCI.

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

Part I of the 16th EBC consensus document presents a detailed analysis of possible pitfalls associated with each step of the provisional single stent approach and it provides a compendium of the pertinent strategies for rescue and prevention. Also included in this review: lead author Remo Albiero...

Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Although the default strategy remains a stepwise provisional strategy, the authors of the 16th expert consensus document recognize that up to 25 % of all single stent approaches eventually require a second.

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Aaysha Cader interviews Rania Hammami, Principal Investigator of the RIVARAD trial. They discuss the design and results of the trial which was presented during #TCT2022.

RIVARAD is the first multicentric randomized trial with 30-day RAOs as the primary endpoint, which proved the efficacy of short-term use of...

Pierre Deharo and Michele Pighi share with us their views on the EXIT-CALC study presented by Thomas Oomens at TCT 2022.

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Discover the case of a 53 year-old woman presenting with severe retrosternal chest pain. ECG revealed an acute inferior ST segment elevation myocardial infarction and angiography showed an acute thrombotic occlusion of the right coronary artery. However, a complication occurred during the primary PCI: the wire...

This toolbox provides interesting information on which expandable sheath fits which prosthesis.

Discover the case of a 74 year-old male presenting with NSTEMI, with an history of lung CA with lobectomy and radiation therapy. The team decided to perform a PCI. How did the procedure go? What challenges did they face and how did they manage them? Watch...

Discover the case of a 36 year-old woman presenting with squizzing central chest pain and referred for a primary PCI with impression of anterior STEMI. Angiography revealed a diffused significant lesion at mid-part of LAD. Watch the video to discover the treatment's option!

Dejan Milasinovic provides his take on the REVIVED trial - percutaneous revascularisation for ischaemic ventricular dysfunction, which was presented during ESC Congress 2022 in Barcelona.

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona